ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

GRTS Gritstone bio Inc

0.80
-0.1728 (-17.76%)
2024年5月11日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Gritstone bio Inc GRTS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.1728 -17.76% 0.80 13:00:06
始値 安値 高値 終値 前日終値
0.8501 0.7821 0.8712 0.7845 0.9728
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/1105:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/5/1005:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1005:07EDGAR2Form 8-K - Current report
2024/5/1005:05GLOBEGritstone bio Reports First Quarter 2024 Financial Results..
2024/5/0305:05GLOBEGritstone bio to Report First Quarter 2024 Financial Results..
2024/4/3020:00GLOBEGritstone bio Highlights the Durability and Potential Broad..
2024/4/2920:00GLOBEGritstone bio Announces Appointment of Stephen Webster to..
2024/4/1520:00GLOBENature Medicine Publishes Interim Results from Gritstone..
2024/4/0821:00GLOBEGritstone bio to Participate in Upcoming Investor and..
2024/4/0820:00GLOBEGritstone bio Presents Improvements to EDGE™ Platform at..
2024/4/0212:00GLOBEGritstone bio Announces Pricing of $32.5 Million..
2024/4/0205:10GLOBEGritstone bio Announces Proposed Public Offering
2024/4/0205:01GLOBEGritstone bio Announces Positive Preliminary..
2024/3/0606:39EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0606:08EDGAR2Form 8-K - Current report
2024/3/0606:05GLOBEGritstone bio Reports Fourth Quarter and Full Year 2023..
2024/3/0106:05GLOBEGritstone bio Announces Workforce Reduction 
2024/2/2121:00GLOBEGritstone bio to Participate in Upcoming Investor and..
2024/2/1402:44EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1221:39EDGAR2Form 8-K - Current report
2024/2/1221:00GLOBEGritstone bio Announces Update to Comparative Phase 2b..
2024/2/0906:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
2024/2/0609:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0609:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0609:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0609:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0609:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1721:00GLOBEGritstone bio to Participate in Upcoming Investor Conference
2024/1/1106:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
2024/1/0214:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/12/2306:06EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/12/0806:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
2023/11/2021:00GLOBEGritstone bio to Participate in Upcoming Investor..
2023/11/0906:06EDGAR2Form 8-K - Current report
2023/11/0906:05GLOBEGritstone bio Reports Third Quarter 2023 Financial Results..
2023/11/0806:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
2023/10/1306:00GLOBEGenevant Sciences LNP Technology Used in samRNA Covid-19..
2023/10/1120:10GLOBEPresentations at IDWeek 2023 Highlight Potentially..
2023/10/1020:00GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
2023/10/0505:05GLOBEGritstone bio Announces Presentations from Phase 1 Studies..
2023/9/2805:07EDGAR2Form 8-K - Current report
2023/9/2805:01GLOBEGritstone bio Awarded BARDA Contract to Conduct Comparative..
2023/9/1405:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
2023/9/0520:00GLOBEGritstone bio to Participate in Upcoming Investor..
2023/8/1705:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
2023/8/1520:21EDGAR2Form 8-K - Current report
2023/8/1520:00GLOBEGritstone bio and Genevant Sciences Announce Option and..
2023/8/1005:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1005:08EDGAR2Form 8-K - Current report
2023/8/1005:05GLOBEGritstone bio Reports Second Quarter 2023 Financial Results..

最近閲覧した銘柄

Delayed Upgrade Clock